Literature DB >> 4902581

Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections.

H C Neu, H Swarz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4902581     DOI: 10.7326/0003-4819-71-5-903

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

Review 1.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

2.  Pseudomonas aeruginosa meningitis treated with an azlocillin combination.

Authors:  S Davidson; E O Yellin; I Shaked; E Rubinstein
Journal:  Infection       Date:  1982       Impact factor: 3.553

3.  Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins.

Authors:  C Thornsberry; C N Baker; L A Kirven; J M Swenson
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

5.  Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors:  H C Neu; G J Garvey
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

6.  Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.

Authors:  M F Parry; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Comparative in vitro evaluation of the effects of ticarcillin and carbenicillin upon Psuedomonas aeruginosa.

Authors:  E Kalkani; N Marketos
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

8.  Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.

Authors:  H C Neu; E B Winshell
Journal:  Appl Microbiol       Date:  1971-01

9.  Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.

Authors:  R Enat; S Pollack; Y Ben-Arieh; E Livni; D Barzilai
Journal:  Br Med J       Date:  1980-04-05

10.  Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.